Summaries & Associations of Study Results
TR-432 Barium Chloride Dihydrate
Target Organs and Levels of Evidence
NTP Technical Report Number 432
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| BARIUM CHLORIDE DIHYDRATE 10326-27-9 |
06/22/93 | CHEMICAL REAGENT. BOILER COMPOUNDS. PIGMENTS AND TEXTILE DYEING. (2) | Dosed-Water 0,500,1200,2500 PPM | T.S.I. Mason Laboratories, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| OTHER :CONSIDERATIONS: | HEMATOPOIETIC SYSTEM: MONONUCLEAR CELL LEUKEMIA 35/50 25/50 26/50 15/50 | |||
| ADRENAL GLAND: PHEOCHROMOCYTOMA 11/49 9/50 10/49 6/50 MALIGNANT PHEOCHROMOCYTOMA 2/49 2/50 2/49 0/50 COMBINED 13/49 11/50 12/49 6/50 | ||||
| FR: NO EVIDENCE | ||||
| MM: NO EVIDENCE | ||||
| OTHER :CONSIDERATIONS: | LIVER: ADENOMA 24/51 20/50 15/48 8/50 | |||
| NON-NEOPLASTIC LESIONS: | KIDNEY: NEPHROPATHY | |||
| FM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | KIDNEY: NEPHROPATHY | |||
Web page last updated on February 10, 2006
